Target intelligence / Profile preview

Viral protein kinase

Molecular classification
Enzyme, Protein kinase, Serine/threonine kinase (most commonly), Dual-specificity kinase (some, e.g., F10 in poxviruses), Viral protein
01

Overview

Viral protein kinases are enzymes encoded by viruses (notably large DNA viruses such as herpesviruses and poxviruses) that catalyze the transfer of a phosphate group from ATP to select serine, threonine, or tyrosine residues of protein substrates. Viral kinases (such as UL13, US3, UL97, U69, BGLF4, and ORF36) play crucial roles in the viral life cycle, including phosphorylation of both viral and host proteins to regulate DNA replication, virion assembly, immune evasion, and cell cycle control. Several are targets of approved or experimental antiviral drugs and have roles in pathogenesis of infection-associated diseases, including certain cancers. The category "viral protein kinase" is generic and encompasses multiple specific enzymes, so more precise identification (e.g., "HCMV UL97 protein kinase") is preferred for structured pharmaceutical work.

Other names
Viral serine/threonine protein kinaseViral kinaseHerpesviral protein kinaseCHPK (Conserved herpesvirus protein kinase; in herpesviruses, specific names include UL13, US3, UL97, U69, BGLF4, ORF36 depending on virus)
02

Mechanism of action

Inhibition of viral protein kinases blocks phosphorylation events essential for viral replication and assembly Inhibition can disrupt activation/protection of viral or host cell proteins needed for virus survival

03

Biological functions

Phosphorylation of viral and host proteinsRegulation of viral replication and assemblyModulation of host immune response (e.g., phosphorylation of IRF-3, Lamin A/C, Rb protein)Control of cell cycle and apoptosis (via targeting of host cell proteins)
04

Disease associations

Infection (various viral infections, particularly herpesviruses and poxviruses)Cancer (contributing to viral oncogenesis, particularly in viruses like Kaposi’s Sarcoma-associated herpesvirus/KSHV)Immune evasion
05

Safety considerations

Selectivity: Homology between viral and some host cell kinases can lead to off-target toxicityResistance: Mutations in viral kinase genes may reduce drug efficacy (notably for HCMV UL97)Host immune modulation: Targeting viral kinases may have unpredictable effects on immune response
06

Interacting drugs

Maribavir (targets HCMV UL97)

2 more in the full profile.

07

Biomarkers

Phosphorylation status of viral kinase substrates (e.g., Lamin A/C, Rb, IRF-3)Viral kinase gene expression or presence (e.g., UL97 for HCMV)

Beyond the preview

Go deeper on Viral protein kinase.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viral protein kinase.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call